The launch of drugs considered as priority drugs, which represented significant therapeutic gains over the existing drugs for the patients and the medical community ranked particularly high.
In the pre-marketing stage, prior to the launch of a drug, clinical trials are used to gather information on both the efficacy and safety of a drug.
Other post-approval measures, such as risk management programmes, pharmacovigilance studies, or phased launch of the drug, may be useful to ensure that risks associated with new treatments are identified and minimised.
Novartis Hit As Key Pain Drug Delayed In U.S. Shares in Novartis fell more than 2% in Europe on Wednesday after U.S. regulators delayed the launch of pain drug Prexige, a potential blockbuster for the Swiss healthcare group, pending more clinical data.
Because DSRU targets all prescriptions that were issued since the launch of the drug of interest, it can be considered as an active post-marketing surveillance system.
We suggest that the main focus of EPV should be after launch of a drug, which will help to identify any possible risks throughout the life of the product.
This evidence came soon after a review ordered by the Japanese government, in part triggered by the 567 serious neuropsychiatric cases received since the 2001 launch of the drug and May 2007.
Subsequent endocrine profiling in humans showed that letrozole was an extremely powerful inhibitor of aromatase; and this, along with our conviction and belief in the compound, led to the fast-tracking of the letrozole clinical program within Novartis and to the subsequent launch of the drug.
These data are in agreement with corresponding longitudinal data from the international PROTEKT Global study (1999 2003), which indicate that no significant change in telithromycin susceptibility has been observed since the launch of the drug in some European countries in 2000 2001 [ 55, 56].
Respondents also noted that the approval and launch of new drugs, and particularly the development of new cancer drugs, gave the pharmaceutical industry a positive image.
We anticipate the expenditure for antiviral drugs will increase due to the continued launch of new drugs for the treatment of HIV and hepatitis B and C. The numbers of patients treated for HIV will increase due to improved survival and ongoing transmission [ 39].
